HomeEVMN • NYSE
add
Evommune Inc
Previous close
$15.01
Day range
$15.00 - $19.40
Year range
$13.89 - $24.03
Market cap
575.31M USD
Avg Volume
205.90K
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 10.00M | — |
Operating expense | 23.33M | 41.24% |
Net income | -12.48M | 21.62% |
Net profit margin | -124.75 | — |
Earnings per share | -8.07 | — |
EBITDA | -13.02M | 19.58% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 76.06M | — |
Total assets | 84.54M | — |
Total liabilities | 10.68M | — |
Total equity | 73.87M | — |
Shares outstanding | 31.52M | — |
Price to book | -0.13 | — |
Return on assets | -36.87% | — |
Return on capital | -41.35% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -12.48M | 21.62% |
Cash from operations | -9.64M | 63.26% |
Cash from investing | -23.91M | -353.99% |
Cash from financing | -274.00K | -140.35% |
Net change in cash | -33.82M | -99.75% |
Free cash flow | -5.12M | — |
About
Founded
2020
Headquarters
Website
Employees
45
